Should New Zealand continue signing up to the Pethidine Protocol?
Pethidine is no longer considered a first-line analgesic. The evidence for this view is critically presented. Clinicians around the World recommend its removal from health-systems or restriction of its use. New Zealand needs to follow these trends.
Shipton
Edward
E
Department of Anaesthesia, Christchurch School of Medicine, Christchurch, New Zealand. ted.shipton@cdhb.govt.nz
D000701:Analgesics, Opioid / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation / Q000379:methods; D004347:Drug Interactions; D004335:Drug and Narcotic Control / Q000639:trends; D005260:Female; D006801:Humans; D008614:Meperidine / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009520:New Zealand; D009293:Opioid-Related Disorders; D010146:Pain / Q000188:drug therapy*; D011247:Pregnancy
D000701:Analgesics, Opioid; D008614:Meperidine